Drug Research
Oligonucleotide Drugs To Witness Novel Sterilisation Process
There is a new report which has gone on to review the processing of the present state of sterile oligonucleotide drug product. This includes recommendations to help in the evaluation and development of the terminal sterilisation processes, as well...
Drug Research
Foetal Development Protein Can Aid Acute Leukaemia Aversion
A protein present in foetal development has been zeroed upon by the researchers that has a strong prophylactic effect versus acute myeloid leukaemia- AML.
Right during the foetal pregnancy stage, numerous vital cell programmes become active in the foetal development....
Drug Research
STAT5 To Play A Crucial Role In The Fight Against Cancer
STAT5 has long been regarded as an interesting target versus cancer, but after several decades of research, it was relegated to the undruggable category. Now, researchers at the University of Michigan Rogel Cancer Center have found success with a...
News
4 Things You Should Know About Benefits For People With Disabilities
People with disabilities or PwDs require assistance and support from healthcare professionals to ensure their health and overall well-being. Since disabilities significantly impair cognitive, physical, and sensory functions, proper medication and treatments are necessary. However, healthcare services for people...
Drug Research
Location of Receptor Crucial For Effects of Psychedelic Drug
For psychedelic medications to effectively cure mental disease by swiftly re-establishing connections between nerve cells, the location happens to be crucial. In a study published on February 17 in Science, scientists from the University of California, Davis, demonstrate that...
Drug Research
Glenmark Pharma receives 2nd US FDA tentative approval for generic Onglyza tablets
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received a 2nd tentative approval by the United States Food & Drug Administration (FDA) for saxagliptin tablets, 2.5 mg and 5 mg, the generic version of Onglyza tablets, 2.5 mg and 5 mg,...
Drug Research
University of East Anglia researchers make a breakthrough for next gen cancer treatment
University of East Anglia researchers make breakthrough for ‘next gen’ cancer treatment. These new treatments would be highly targeted and more effective than current state-of-the-art cancer immunotherapies.
New research published today reveals the science behind this innovative idea. It shows how...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















